Credentialing
North Central Cancer Treatment Group (NCCTG) |
|
Activated protocol list | Closed protocol list |
|
ALL NCCTG radiotherapy facilities must complete the IROC Houston 3D benchmark case, additional credentialing may be required for specific protocols.
N0577 | --- |
Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma.
|
|||
Link to Protocols | |||||
|
|||||
Note: If you need help with the protocol links, please contact the NCCTG Operations Office or the CTSU Help Desk (1-888-823-5923 or ctsucontact@westat.com) |